Phase II Study of Erdafitinib in Patients With Tumors With Fibroblast Growth Factor Receptor Mutations or Fusions: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K2.
Article in JCO Precision Oncology (May 2024)
The most recent citing publications are shown below. View all 45 publications that cite this research output on Dimensions.
Article in JCO Precision Oncology (May 2024)
Article in Brain Communications (March 2024)
Article in Life Sciences (February 2024)